Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum

Background: Placenta previa (PP) combined with placenta accreta spectrum (PAS) is a serious obstetric condition that increases the risk of maternal and fetal complications. Early diagnosis is therefore crucial for improving outcomes. The aim of this study was to evaluate the accur...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Wang, Zhengdong Hou, Bingqing Xia, Xianjing Xie, Ying He
Format: Article
Language:English
Published: IMR Press 2025-01-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/52/1/10.31083/CEOG26095
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586563305865216
author Ying Wang
Zhengdong Hou
Bingqing Xia
Xianjing Xie
Ying He
author_facet Ying Wang
Zhengdong Hou
Bingqing Xia
Xianjing Xie
Ying He
author_sort Ying Wang
collection DOAJ
description Background: Placenta previa (PP) combined with placenta accreta spectrum (PAS) is a serious obstetric condition that increases the risk of maternal and fetal complications. Early diagnosis is therefore crucial for improving outcomes. The aim of this study was to evaluate the accuracy of magnetic resonance imaging (MRI) combined with three serological markers (alpha-fetoprotein [AFP], creatine kinase [CK], and soluble fms-like tyrosine kinase-1 [sFlt-1]) for the diagnosis of PP with PAS. Methods: This retrospective study included 243 patients with suspected PP and PAS treated at two hospitals between August 2018 and August 2023. Patients were divided into two groups based on surgical and pathological findings: PP+PAS (+) and PP+PAS (–). The serum levels of AFP, CK, and sFlt-1 were measured, and optimal diagnostic thresholds were determined using receiver operating characteristic (ROC) curve analysis. The diagnostic performance of MRI, serological markers, and a combination of the two was compared with that of surgical pathology. Results: Serum AFP, CK, and sFlt-1 levels were significantly higher in the PP+PAS (+) group compared to the PP+PAS (–) group. The optimal thresholds of AFP, CK, and sFlt-1 for the diagnosis of PP+PAS (+) were 58.49 U/mL, 168.25 U/mL, and 2.28 ng/mL, respectively. A combined diagnostic approach using MRI and serological markers showed good accuracy, with a Kappa coefficient of 0.850, indicating good agreement with surgical pathology. Conclusions: Combining MRI with serological markers (AFP, CK, and sFlt-1) provides enhanced diagnostic accuracy for detecting PP with PAS as compared to either method alone. This approach can facilitate early diagnosis, improve clinical decision-making, and reduce the risks associated with surgical intervention.
format Article
id doaj-art-36dd2adc7e0d40b38cae6a118064f485
institution Kabale University
issn 0390-6663
language English
publishDate 2025-01-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-36dd2adc7e0d40b38cae6a118064f4852025-01-25T07:14:26ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632025-01-015212609510.31083/CEOG26095S0390-6663(24)02531-4Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta SpectrumYing Wang0Zhengdong Hou1Bingqing Xia2Xianjing Xie3Ying He4Department of Obstetrics, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, 200030 Shanghai, ChinaDepartment of Radiology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, 200233 Shanghai, ChinaShanghai Key Laboratory of Embryo Original Disease, 200030 Shanghai, ChinaDepartment of Obstetrics, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, 200030 Shanghai, ChinaDepartment of Obstetrics, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, 200030 Shanghai, ChinaBackground: Placenta previa (PP) combined with placenta accreta spectrum (PAS) is a serious obstetric condition that increases the risk of maternal and fetal complications. Early diagnosis is therefore crucial for improving outcomes. The aim of this study was to evaluate the accuracy of magnetic resonance imaging (MRI) combined with three serological markers (alpha-fetoprotein [AFP], creatine kinase [CK], and soluble fms-like tyrosine kinase-1 [sFlt-1]) for the diagnosis of PP with PAS. Methods: This retrospective study included 243 patients with suspected PP and PAS treated at two hospitals between August 2018 and August 2023. Patients were divided into two groups based on surgical and pathological findings: PP+PAS (+) and PP+PAS (–). The serum levels of AFP, CK, and sFlt-1 were measured, and optimal diagnostic thresholds were determined using receiver operating characteristic (ROC) curve analysis. The diagnostic performance of MRI, serological markers, and a combination of the two was compared with that of surgical pathology. Results: Serum AFP, CK, and sFlt-1 levels were significantly higher in the PP+PAS (+) group compared to the PP+PAS (–) group. The optimal thresholds of AFP, CK, and sFlt-1 for the diagnosis of PP+PAS (+) were 58.49 U/mL, 168.25 U/mL, and 2.28 ng/mL, respectively. A combined diagnostic approach using MRI and serological markers showed good accuracy, with a Kappa coefficient of 0.850, indicating good agreement with surgical pathology. Conclusions: Combining MRI with serological markers (AFP, CK, and sFlt-1) provides enhanced diagnostic accuracy for detecting PP with PAS as compared to either method alone. This approach can facilitate early diagnosis, improve clinical decision-making, and reduce the risks associated with surgical intervention.https://www.imrpress.com/journal/CEOG/52/1/10.31083/CEOG26095placenta previaplacenta accreta spectrummagnetic resonance imagingserological indicatorsdiagnostic value
spellingShingle Ying Wang
Zhengdong Hou
Bingqing Xia
Xianjing Xie
Ying He
Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
Clinical and Experimental Obstetrics & Gynecology
placenta previa
placenta accreta spectrum
magnetic resonance imaging
serological indicators
diagnostic value
title Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
title_full Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
title_fullStr Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
title_full_unstemmed Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
title_short Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
title_sort magnetic resonance imaging combined with serological markers improves the diagnosis of placenta previa with placenta accreta spectrum
topic placenta previa
placenta accreta spectrum
magnetic resonance imaging
serological indicators
diagnostic value
url https://www.imrpress.com/journal/CEOG/52/1/10.31083/CEOG26095
work_keys_str_mv AT yingwang magneticresonanceimagingcombinedwithserologicalmarkersimprovesthediagnosisofplacentapreviawithplacentaaccretaspectrum
AT zhengdonghou magneticresonanceimagingcombinedwithserologicalmarkersimprovesthediagnosisofplacentapreviawithplacentaaccretaspectrum
AT bingqingxia magneticresonanceimagingcombinedwithserologicalmarkersimprovesthediagnosisofplacentapreviawithplacentaaccretaspectrum
AT xianjingxie magneticresonanceimagingcombinedwithserologicalmarkersimprovesthediagnosisofplacentapreviawithplacentaaccretaspectrum
AT yinghe magneticresonanceimagingcombinedwithserologicalmarkersimprovesthediagnosisofplacentapreviawithplacentaaccretaspectrum